PPARGC1A and melanoma: While enhanced glycolysis favors metastatic behavior in melanoma cells and several elements of the glycolytic pathway are considered as prognostic markers [25,26], some melanoma cells characterized by high expression of the peroxisome proliferator-activated receptor γ coactivator 1α (PGC1α), exhibit greater dependency on oxidative phosphorylation [27].